• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨闪烁扫描呈超级超级影像。

Super-superscan on a bone scintigraphy.

机构信息

Department of Radiology, Nuclear Medicine Service, University Hospital, UMDNJ, Newark, NJ 07103, USA.

出版信息

Clin Nucl Med. 2011 Mar;36(3):227-8. doi: 10.1097/RLU.0b013e318208f503.

DOI:10.1097/RLU.0b013e318208f503
PMID:21285685
Abstract

Superscans on bone scintigraphy have been described mostly in metastatic and metabolic bone diseases, with different patterns and appearances of radiotracer uptake. This is a report of bone scintigraphy demonstrating superimposed metastatic and metabolic superscan in a patient with prostate cancer, who subsequently developed renal osteodystrophy. Two years after the first bone scintigraphy showing multiple metastases, the patient developed renal insufficiency, hyperphosphoremia, and hypocalcemia. Repeat bone scintigraphy demonstrates significantly different appearance from that of the first study. Caution should be exercised when interpreting a bone scintigraphy in patients with known malignancy and coexisting renal failure or metabolic bone disease. Superimposed appearances of metastatic and metabolic superscan may obscure recognition of osseous metastases.

摘要

骨闪烁扫描术上的超级影像大多见于转移性和代谢性骨疾病,其放射性示踪剂摄取呈现不同的模式和外观。这是一例前列腺癌患者的骨闪烁扫描术报告,该患者随后发展为肾性骨营养不良。首次骨闪烁扫描术显示多发性转移后两年,患者出现肾功能不全、高磷血症和低钙血症。重复骨闪烁扫描术显示出与第一次研究明显不同的外观。在已知患有恶性肿瘤且同时伴有肾衰竭或代谢性骨疾病的患者中,对骨闪烁扫描术的解释应谨慎。转移性和代谢性超级影像的叠加可能会掩盖对骨转移的识别。

相似文献

1
Super-superscan on a bone scintigraphy.骨闪烁扫描呈超级超级影像。
Clin Nucl Med. 2011 Mar;36(3):227-8. doi: 10.1097/RLU.0b013e318208f503.
2
The role of Tc-99m (V) DMSA scintigraphy in the evaluation of superscan on bone scintigraphy.锝-99m(V)二巯基丁二酸闪烁扫描术在骨闪烁扫描术中对超级骨显像评估中的作用。
Clin Nucl Med. 2000 Mar;25(3):193-6. doi: 10.1097/00003072-200003000-00008.
3
Abnormally increased uptake on bone scintigraphy in the long bone proximal to a tourniquet: an injection artifact.止血带近端长骨在骨闪烁扫描上摄取异常增加:一种注射伪影。
Clin Nucl Med. 2010 May;35(5):349-50. doi: 10.1097/RLU.0b013e3181d626c2.
4
99mTc bone scintigraphy superscans: a review.99m锝骨闪烁扫描超扫描:综述
Nucl Med Commun. 2007 Jul;28(7):521-7. doi: 10.1097/MNM.0b013e3281744440.
5
Coexistent Superscan and Lincoln Sign on Bone Scintigraphy.骨闪烁扫描同时存在超级影像和林肯征。
Clin Nucl Med. 2017 Aug;42(8):630-632. doi: 10.1097/RLU.0000000000001714.
6
Ivory vertebra appearing photopenic on Tc-99m MDP bone scan: demonstration by SPECT/CT.在锝-99m亚甲基二膦酸盐(Tc-99m MDP)骨扫描上呈放射性缺损的象牙椎:单光子发射计算机断层扫描/计算机断层扫描(SPECT/CT)显示
Clin Nucl Med. 2008 Jul;33(7):479-81. doi: 10.1097/RLU.0b013e31817793e5.
7
[Bone scintigraphy in evaluation of the effect of renal transplantation in patients with renal osteodystrophy].[骨闪烁显像在评估肾性骨营养不良患者肾移植效果中的应用]
Rinsho Hoshasen. 1989 Nov;34(12):1433-6.
8
Visualization of discrete sacral foramina as an ancillary sign of superscan.可视化离散骶孔作为超级扫描的辅助征象。
Clin Nucl Med. 2011 Jan;36(1):21-4. doi: 10.1097/RLU.0b013e3181feeb8c.
9
A large soft-tissue lipoma shown on bone scintigraphy.骨扫描显示一个大的软组织脂肪瘤。
Clin Nucl Med. 2013 Jun;38(6):484-5. doi: 10.1097/RLU.0b013e31828733d0.
10
Comparison of whole-body MRI and bone scintigraphy in the detection of bone metastases in renal cancer.全身MRI与骨闪烁显像在肾癌骨转移检测中的比较
Br J Radiol. 2009 Aug;82(980):632-9. doi: 10.1259/bjr/52773262. Epub 2009 Feb 16.

引用本文的文献

1
Use of bone-SPECT/CT and Na[F]F-PET/CT in hyperparathyroidism.骨SPECT/CT和Na[F]F-PET/CT在甲状旁腺功能亢进症中的应用。
Front Nucl Med. 2025 Apr 16;5:1565906. doi: 10.3389/fnume.2025.1565906. eCollection 2025.
2
Metastatic Superscan in F PSMA PET/CT of a Patient with Prostate Carcinoma.前列腺癌患者F-PSMA PET/CT检查中的转移性超级骨显像
Mol Imaging Radionucl Ther. 2024 Feb 22;33(1):38-39. doi: 10.4274/mirt.galenos.2023.68815.
3
[Guidelines for Evaluating Treatment Response Based on Bone Scan for Metastatic Castration-Resistant Prostate Cancer: Prostate Cancer Clinical Trial Working Group 3 Recommendations].
[基于骨扫描评估转移性去势抵抗性前列腺癌治疗反应的指南:前列腺癌临床试验工作组3的建议]
J Korean Soc Radiol. 2023 Nov;84(6):1244-1256. doi: 10.3348/jksr.2023.0060. Epub 2023 Oct 27.
4
Associations between Normal Organs and Tumor Burden in Patients Imaged with Fibroblast Activation Protein Inhibitor-Directed Positron Emission Tomography.使用成纤维细胞活化蛋白抑制剂导向正电子发射断层扫描成像的患者中正常器官与肿瘤负荷之间的关联
Cancers (Basel). 2022 May 25;14(11):2609. doi: 10.3390/cancers14112609.
5
Differential Diagnosis of Rare Diseases Involving Bilateral Lower Extremities with Similar Tc-MDP Bone Scan Patterns: Analysis of a Case Series.涉及双侧下肢且Tc-MDP骨扫描模式相似的罕见疾病的鉴别诊断:病例系列分析
Diagnostics (Basel). 2022 Apr 6;12(4):910. doi: 10.3390/diagnostics12040910.
6
Recent Updates on Molecular Imaging Reporting and Data Systems (MI-RADS) for Theranostic Radiotracers-Navigating Pitfalls of SSTR- and PSMA-Targeted PET/CT.用于治疗诊断放射性示踪剂的分子影像报告和数据系统(MI-RADS)的最新进展——应对生长抑素受体(SSTR)和前列腺特异性膜抗原(PSMA)靶向PET/CT的陷阱
J Clin Med. 2019 Jul 19;8(7):1060. doi: 10.3390/jcm8071060.
7
Semiquantitative Parameters in PSMA-Targeted PET Imaging with [F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake.[F]DCFPyL 标记的 PSMA 靶向 PET 成像中的半定量参数:肿瘤负荷对正常器官摄取的影响。
Mol Imaging Biol. 2020 Feb;22(1):190-197. doi: 10.1007/s11307-019-01375-w.
8
Impact of Tumor Burden on Quantitative [Ga] DOTATOC Biodistribution.肿瘤负荷对定量 [Ga] DOTATOC 生物分布的影响。
Mol Imaging Biol. 2019 Aug;21(4):790-798. doi: 10.1007/s11307-018-1293-9.
9
Superscan on Methylene Diphosphonate Skeletal Scintigraphy in Prostatic Adenocarcinoma: A Common Finding but Rare Etiology.前列腺腺癌中甲基二膦酸盐骨闪烁显像的超级骨显像:一种常见表现但病因罕见
Indian J Nucl Med. 2017 Oct-Dec;32(4):369-371. doi: 10.4103/ijnm.IJNM_95_17.
10
Whole-Body SPECT/CT versus Planar Bone Scan with Targeted SPECT/CT for Metastatic Workup.全身SPECT/CT与平面骨扫描联合靶向SPECT/CT用于转移灶检查
Biomed Res Int. 2017;2017:7039406. doi: 10.1155/2017/7039406. Epub 2017 Jul 24.